Transformatieve resultaten op het gebied van gewichtsverlies op lange termijn tonen aan dat 95% van het totale lichaamsgewichtsverlies bereikt tijdens de behandeling met Elipse Balloon gehandhaafd bleef op 1 jaar
Opeenvolgende ballonbehandeling bereikt gewichtsverlies na 1 jaar, wat ongeveer overeenkomt met bariatrische chirurgie
NATICK, Mass. – (BUSINESS WIRE) – Allurion Technologies, een baanbrekende leider in de ontwikkeling van innovatieve, schaalbare en vertrouwde ervaringen met gewichtsverlies, heeft vandaag nieuwe klinische gegevens over de Elipse-ballon aangekondigd op ObesityWeek 2020. Het Allurion-programma omvat de Elipse-ballon, ‘s werelds eerste en enige procedureloze apparaat voor gewichtsverlies. De ballon is ontworpen om 4 maanden in de maag te blijven en is gekoppeld aan een met Bluetooth® verbonden weegschaal en Allurion smartphone-app en een begeleid voedingsprogramma.
Allurion Technologies Announces New Clinical Data on the Elipse® Balloon at ObesityWeek® 2020
Transformative long-term weight loss results show 95% of total body weight loss achieved during Elipse Balloon treatment was maintained at 1-year
Sequential balloon treatment achieves weight loss at 1-year that approximates bariatric surgery
NATICK, Mass.–(BUSINESS WIRE)– Allurion Technologies, a pioneering leader in the development of innovative, scalable and trusted weight loss experiences, today announced new clinical data on the Elipse Balloon at ObesityWeek 2020. The Allurion Program features the Elipse Balloon, the world’s first and only procedureless weight loss device. The balloon is designed to remain in the stomach for 4 months and is paired with a Bluetooth® connected scale and Allurion smartphone app and a supervised nutritional program.
In Long-Term Efficacy of the Elipse Gastric Balloon System: An International Multicenter Study, Dr. Roberta Ienca and colleagues report on 509 patients who received the Elipse Balloon and were followed for one year. After 4 months of Elipse Balloon treatment patients achieved weight loss of 14.4 ± 7.7kg or 13.9 ± 6.4% of total body weight. At one-year follow-up, 95% of this weight loss was sustained.
In Sequential Elipse Balloon Treatment: 1-Year Weight Loss Results Approximates Bariatric Surgery Results, Dr. Roberta Ienca and colleagues report on 42 patients treated with sequential Elipse Balloons. Between one and five months following the passing of the first Elipse Balloon, a second balloon was placed. After 4 months, mean weight loss and percent total body weight loss were 14.7 ± 4.4kg and 14.4 ± 3.6%, respectively. The second balloon resulted in an additional 8.8 ± 5.7kg and 10.0 ± 6.5% weight loss, respectively. In total, sequential balloon treatment resulted in weight loss of 22.0 +/- 9.0kg or 22.8 +/- 8.8%, and a body mass index (BMI) decrease of 8.1kg/m2 from baseline.
“Both of these studies demonstrate the potential that the Allurion Program has in providing consumers with long-term and sustainable results,” said Dr. Shantanu Gaur, co-founder and CEO of Allurion. “Additionally, this data indicates that consumers can achieve life-changing results without needing to undergo surgery, endoscopy or anesthesia.”
“The Elipse Balloon provides my patients with a primary weight loss tool and an alternative to weight loss surgery,” said Dr. Alberto Pagan, Clinica CINIB, Palma de Mallorca, Spain. “These results underscore how the Allurion Program can deliver both short and long-term results that meet the expectations of my patients.”
“The clinical data presented at Obesity Week is reflective of the increasing demand for our product around the world,” said Benoit Chardon, Executive Vice President Commercial for Allurion. “We have tripled the number of patients treated in the past year and have created a reputation for clinical results that providers and patients can trust.”
About Allurion Technologies
Allurion Technologies is dedicated to helping people realize their full potential with innovative, scalable and trusted experiences. The company’s flagship product, the Allurion Program, is a 360-degree weight loss experience featuring the Elipse Balloon, the world’s first and only swallowable, procedureless gastric balloon for weight loss. Learn more about the Elipse Balloon and Allurion online at www.allurion.com, on Facebook at www.fb.com/allurion or on Twitter @alluriontech.